|
1
|
Schirbel A and Fiocchi C: Inflammatory
bowel disease: Established and evolving considerations on its
etiopathogenesis and therapy. J Dig Dis. 11:266–276. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baumgart DC and Carding SR: Inflammatory
bowel disease: cause and immunobiology. Lancet. 369:1627–1640.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hisamatsu T, Kanai T, Mikami Y, et al:
Immune aspects of the pathogenesis of inflammatory bowel disease.
Pharmacol Ther. 137:283–297. 2013. View Article : Google Scholar
|
|
4
|
Műzes G, Molnár B, Tulassay Z and Sipos F:
Changes of the cytokine profile in inflammatory bowel diseases.
World J Gastroenterol. 18:5848–5861. 2012. View Article : Google Scholar :
|
|
5
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Zoeten E and Mamula P: What are the
guidelines for using biologics in pediatric patients? Inflamm Bowel
Dis. 14(Suppl 2): S259–S261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taba Taba Vakili S, Taher M and Ebrahimi
Daryani N: Update on the management of ulcerative colitis. Acta Med
Iran. 50:363–372. 2012.PubMed/NCBI
|
|
8
|
Parekkadan B and Milwid JM: Mesenchymal
stem cells as therapeutics. Annu Rev Biomed Eng. 12:87–117. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Meyerrose T, Olson S, Pontow S, et al:
Mesenchymal stem cells for the sustained in vivo delivery of
bioactive factors. Adv Drug Deliv Rev. 62:1167–1174. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Blanc K, Tammik C, Rosendahl K,
Zetterberg E and Ringdén O: HLA expression and immunologic
properties of differentiated and undifferentiated mesenchymal stem
cells. Exp Hematol. 31:890–896. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Le Blanc K, Tammik L, Sundberg B,
Haynesworth SE and Ringdén O: Mesenchymal stem cells inhibit and
stimulate mixed lymphocyte cultures and mitogenic responses
independently of the major histocompatibility complex. Scand J
Immunol. 57:11–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dalal J, Gandy K and Domen J: Role of
mesenchymal stem cell therapy in Crohn’s disease. Pediatr Res.
71:445–451. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ringdén O, Uzunel M, Rasmusson I, et al:
Mesenchymal stem cells for treatment of therapy-resistant
graft-versus-host disease. Transplantation. 81:1390–1397. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun S, Guo Z, Xiao X, et al: Isolation of
mouse marrow mesenchymal progenitors by a novel and reliable
method. Stem Cells. 21:527–535. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morris GP, Beck PL, Herridge MS, et al:
Hapten-induced model of chronic inflammation and ulceration in the
rat colon. Gastroenterology. 96:795–803. 1989.PubMed/NCBI
|
|
16
|
Davaatseren M, Hwang JT, Park JH, et al:
Poly-γ-glutamic acid attenuates angiogenesis and inflammation in
experimental colitis. Mediators Inflamm. 2013:9823832013.
View Article : Google Scholar
|
|
17
|
González R, Rodríguez S, Romay C, et al:
Anti-inflammatory activity of phycocyanin extract in acetic
acid-induced colitis in rats. Parmacol Res. 39:55–59. 1999.
|
|
18
|
Guo Y, Su L, Wu J, et al: Assessment of
the green fluorescence protein labeling methods for tracking
implanted mesenchymal stem cells. Cytotechnology. 64:391–401. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi T and Song SU: Immunomodulatory
properties of mesenchymal stem cells and their therapeutic
applications. Arch Pharm Res. 35:213–221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Uccelli A, Moretta L and Pistoia V:
Mesenchymal stem cells in health and disease. Nat Rev Immunol.
8:726–736. 2008. View
Article : Google Scholar
|
|
21
|
Tolar J, Le Blanc K, Keating A and Blazar
BR: Concise review: hitting the right spot with mesenchymal stromal
cells. Stem Cells. 28:1446–1455. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Krampera M, Cosmi L, Angeli R, et al: Role
for interferon-gamma in the immunomodulatory activity of human bone
marrow mesenchymal stem cells. Stem Cells. 24:386–398. 2006.
View Article : Google Scholar
|
|
23
|
Tanaka F, Tominaga K, Ochi M, et al:
Exogenous administration of mesenchymal stem cells ameliorates
dextran sulfate sodium-induced colitis via anti-inflammatory action
in damaged tissue in rats. Life Sci. 83:771–779. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
|
25
|
Idriss HT and Naismith JH: TNF alpha and
the TNF receptor superfamily: structure-function relationship(s).
Microsc Res Tech. 50:184–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Locksley RM, Killeen N and Lenardo MJ: The
TNF and TNF receptor superfamilies: integrating mammalian biology.
Cell. 104:487–501. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Smith CA, Farrah T and Goodwin RG: The TNF
receptor superfamily of cellular and viral proteins: activation,
costimulation, and death. Cell. 76:959–962. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ogata H and Hibi T: Cytokine and
anti-cytokine therapies for inflammatory bowel disease. Curr Pharm
Des. 9:1107–1113. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng L, Fisher G, Miller RE, et al:
Induction of apoptosis in mature T cells by tumour necrosis factor.
Nature. 377:348–351. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noti M, Corazza N, Mueller C, Berger B and
Brunner T: TNF suppresses acute intestinal inflammation by inducing
local glucocorticoid synthesis. J Exp Med. 207:1057–1066. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Olson TS, Reuter BK, Scott KG, et al: The
primary defect in experimental ileitis originates from a
nonhematopoietic source. J Exp Med. 203:541–552. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reimund JM, Wittersheim C, Dumont S, et
al: Mucosal inflammatory cytokine production by intestinal biopsies
in patients with ulcerative colitis and Crohn’s disease. J Clin
Immunol. 16:144–150. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Armuzzi A, Lionetti P, Blandizzi C,
Caporali R, et al: Anti-TNF agents as therapeutic choice in
immune-mediated inflammatory diseases: focus on adalimumab. Int J
Immunopathol Pharmacol. 27(1 Suppl): 11–32. 2014.PubMed/NCBI
|
|
34
|
Chen FE and Ghosh G: Regulation of DNA
binding by Rel/NF-kappaB transcription factors: structural views.
Oncogene. 18:6845–6852. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barnes PJ and Karin M: Nuclear
factor-kappaB: a pivotal transcription factor in chronic
inflammatory diseases. N Engl J Med. 336:1066–1071. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
DiDonato JA, Hayakawa M, Rothwarf DM,
Zandi E and Karin M: A cytokine-responsive IkappaB kinase that
activates the transcription factor NF-kappaB. Nature. 388:548–554.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schmitz ML, Bacher S and Kracht M: I kappa
B-independent control of NF-kappa B activity by modulatory
phosphorylations. Trends Biochem Sci. 26:186–190. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pizarro TT and Cominelli F: Cytokine
therapy for Crohn’s disease: advances in translational research.
Annu Rev Med. 58:433–444. 2007. View Article : Google Scholar
|
|
39
|
Elson CO, Cong Y and Weaver CT: Monoclonal
anti-interleukin 23 reverses active colitis in a T cell-mediated
model in mice. Gastroenterol. 132:2359–2370. 2007. View Article : Google Scholar
|
|
40
|
Atreya R, Mudter J, Finotto S, et al:
Blockade of interleukin 6 trans signaling suppresses T-cell
resistance against apoptosis in chronic intestinal inflammation:
evidence in crohn disease and experimental colitis in vivo. Nat
Med. 6:583–588. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Suenaert P, Bulteel V, Lemmens L, et al:
Anti-tumor necrosis factor treatment restores the gut barrier in
Crohn’s disease. Am J Gastroenterol. 97:2000–2004. 2002. View Article : Google Scholar : PubMed/NCBI
|
